Streetbeat News

Analyst Ratings

BBSI

Barrington Research analyst Vincent Colicchio maintains an Outperform rating on Barrett Business Services (BBSI) with a price target of $141.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:18 pm

FDMT

BMO Capital analyst Kostas Biliouris maintains an Outperform rating on 4D Molecular Therapeutics (NASDAQ:FDMT) but lowers the price target from $70 to $63.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:18 pm

OPK

Barrington Research analyst Michael Petusky has maintained an Outperform rating on OPKO Health (NASDAQ:OPK) with a price target of $1.5. This reaffirms the firm's positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:16 pm

CCJ

Goldman Sachs analyst Neil Mehta initiates coverage on Cameco (NYSE:CCJ) with a Buy rating and a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:15 pm

SHCR

BTIG analyst David Larsen downgraded Sharecare (NASDAQ:SHCR) from Buy to Neutral, indicating a change in the firm's outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:13 pm

PIII

BTIG analyst David Larsen downgraded P3 Health Partners (NASDAQ:PIII) from Buy to Neutral, indicating a shift in the firm's outlook on the company.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:12 pm

ABNB

Wells Fargo analyst Ken Gawrelski maintains an Underweight rating on Airbnb (NASDAQ:ABNB) and raises the price target from $107 to $127.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:10 pm

AVTE

Wells Fargo analyst Tiago Fauth maintains an Overweight rating on Aerovate Therapeutics (NASDAQ:AVTE) and keeps the price target at $35.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 4:07 pm

TCBI

Texas Capital Bancshares Inc (NASDAQ:TCBI) shares fell after Truist Securities predicted the Federal Reserve will cut interest rates, leading analyst Brandon King to downgrade TCBI from Buy to Hold and reduce the price target from $72 to $66. The anticipated rate cuts and other factors are expected to pressure net interest income (NII), with 2024/2025 EPS estimates 12%/13% below consensus.

Portfolio Pulse from Priya Nigam

April 01, 2024 | 4:06 pm